Síndrome de hipermovilidad articular
Acta Ortopédica Mexicana · 2020 · 34 (6) · 441-449
DOI: 10.35366/99145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Ortopédica Mexicana, 2020. Verfasst von R Rodríguez-Romo und 5 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Joint hypermobility syndrome is an inherited disorder with autosomal dominant pattern; is characterized by joint hyperlaxity and musculoskeletal pains. Thermal hypermobility refers to the increase in active or passive movements of joints based on their normal ranges. Joint hypermobility syndrome also has gastrointestinal symptoms, sleep disorders, fibromyalgia, psychological disorders, migraine headache, ophthalmic, autonomic, among others. To diagnose hypermobility syndrome, Brighton’s criteria are generally accepted and published in 1998. This criteria also known as benign joint hypermobility syndrome. The term benign is used to distinguish it from other more severe conditions such as Ehler-Danlos (classic or vascular type), Marfan syndrome, and imperfect osteogenesis. Treatment with physiotherapy and pharmacological means help improve patients’ quality of life.
Zitieren
APA
Rodríguez-Romo, R., Orrantia-Vertiz, M., Barragán-Garfias, J., Rojas-García, G., Rodríguez-Álvarez, A., & Carbonell-Bobadilla, N. (2020). Síndrome de hipermovilidad articular. Acta Ortopédica Mexicana, 34(6), 441-449. https://doi.org/10.35366/99145
Vancouver
Rodríguez-Romo R, Orrantia-Vertiz M, Barragán-Garfias J, Rojas-García G, Rodríguez-Álvarez A, Carbonell-Bobadilla N. Síndrome de hipermovilidad articular. Acta Ortopédica Mexicana. 2020;34(6):441-449. doi:10.35366/99145
BibTeX
@article{RodrguezRomo2020,
author = {Rodríguez-Romo, R and Orrantia-Vertiz, M and Barragán-Garfias, JA and Rojas-García, G and Rodríguez-Álvarez, AA and Carbonell-Bobadilla, N},
title = {Síndrome de hipermovilidad articular},
journal = {Acta Ortopédica Mexicana},
year = {2020},
volume = {34},
number = {6},
pages = {441--449},
doi = {10.35366/99145}
}
EUVIMED